Abstract
Multiple sclerosis (MS) is a chronic, progressive disease characterized by debilitating symptoms and causes great psychological and emotional distress. While fear of disease progression (FoP) has been widely assessed in oncology and other chronic conditions, FoP has been less studied in MS and prevalence of suitable patient reported outcomes (PRO) is unclear. This study aimed to identify existing instruments that have been used to measure FoP, and related concepts, in people with MS (PwMS).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
